Literature DB >> 10830846

Metal complexes of salicylhydroxamic acid (H2Sha), anthranilic hydroxamic acid and benzohydroxamic acid. Crystal and molecular structure of [Cu(phen)2(Cl)]Cl x H2Sha, a model for a peroxidase-inhibitor complex.

E C O'Brien1, E Farkas, M J Gil, D Fitzgerald, A Castineras, K B Nolan.   

Abstract

Stability constants of iron(III), copper(II), nickel(II) and zinc(II) complexes of salicylhydroxamic acid (H2Sha), anthranilic hydroxamic acid (HAha) and benzohydroxamic acid (HBha) have been determined at 25.0 degrees C, I=0.2 mol dm(-3) KCl in aqueous solution. The complex stability order, iron(III) >> copper(II) > nickel(II) approximately = zinc(II) was observed whilst complexes of H2Sha were found to be more stable than those of the other two ligands. In the preparation of ternary metal ion complexes of these ligands and 1,10-phenanthroline (phen) the crystalline complex [Cu(phen)2(Cl)]Cl x H2Sha was obtained and its crystal structure determined. This complex is a model for hydroxamate-peroxidase inhibitor interactions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10830846     DOI: 10.1016/s0162-0134(99)00245-7

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  5 in total

1.  Discovery of a new class of histone deacetylase inhibitors with a novel zinc binding group.

Authors:  Youxuan Li; Patrick M Woster
Journal:  Medchemcomm       Date:  2015-04-01       Impact factor: 3.597

2.  3-Hydroxypyridin-2-thione as novel zinc binding group for selective histone deacetylase inhibition.

Authors:  Vishal Patil; Quaovi H Sodji; James R Kornacki; Milan Mrksich; Adegboyega K Oyelere
Journal:  J Med Chem       Date:  2013-04-18       Impact factor: 7.446

3.  Carbamoylphosphonate-based matrix metalloproteinase inhibitor metal complexes: solution studies and stability constants. Towards a zinc-selective binding group.

Authors:  Etelka Farkas; Yiffat Katz; Sudhakar Bhusare; Reuven Reich; Gerd-Volker Röschenthaler; Martin Königsmann; Eli Breuer
Journal:  J Biol Inorg Chem       Date:  2004-02-05       Impact factor: 3.358

Review 4.  Investigations into small molecule non-peptidic inhibitors of the botulinum neurotoxins.

Authors:  Katerina Capková; Nicholas T Salzameda; Kim D Janda
Journal:  Toxicon       Date:  2009-03-25       Impact factor: 3.033

5.  Hydroxamic acid - A novel molecule for anticancer therapy.

Authors:  Dilipkumar Pal; Supriyo Saha
Journal:  J Adv Pharm Technol Res       Date:  2012-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.